News from MarketWatch Top Stories
What is your interest today?
Tariffs
Ceo
Investors
Stock
Shares
Earnings
Stocks
Eqs
China
Cet
Nasdaq
Investment
Markets
Wall Street
Tesla
Nvidia
Trade
Revenue
Inflation
Stock Market
Securities
Class Action
Bitcoin
Economy
Us
Company
Sales
Apple
Prices
Trade War
Sp 500
Ipo
Federal Reserve
Pvr
Crypto
Companies
Interest Rates
Amazon
Shareholders
Guidance
Warren Buffett
Federal Securities Laws
Elon Musk
Trading
Berkshire Hathaway
German Securities Trading Act
Walmart
Investor
Voting Rights
Profit
Fed
New York City
Cost Of Living Adjustment
Postmaster General
Corporate Earnings
Offshore Wind Project
Mexican Restaurants
Adp Jobs Report
Consumer Brands
Robinhood Markets
MarketWatch Top Stories • May 30, 2025
Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...
Read Full Article →